Sensors Slip into the Brain, Then Dissolve When the Job Is Done

Transient electronics monitor pressure and temperature for five days and then disappear

2 min read
Sensors Slip into the Brain, Then Dissolve When the Job Is Done
Photo: John Rogers/University of Illionis at Urbana-Champaign

Five days. That’s how long intracranial pressure and temperature typically need to be monitored in the case of traumatic brain injury. And that’s at least how long flexible, dissolvable sensors created by a research team at the University of Illinois led by professor John Rogers will operate accurately.

I met Rogers a year ago, interested in the temporary tattoos and other flexible electronics patches he’d been developing that were designed to be so similar to the skin that you could wear them for days without noticing them. Though the majority of his scientists and engineers were involved in making sensors and transmitters as stretchable as his lab’s serpentine silicon circuits, Rogers clearly had his eye on the horizon. In particular, he was after electronics structures that could be implanted seamlessly in the brain or on or around other organs. These sensing, communicating devices would need to have new geometries and new properties to fit in with the complex structures of the body without compromising them. [For the full story see "A Temporary Tattoo That Senses Through Your Skin".]

Today, Rogers released news of his latest breakthrough in silicon biocompatible circuitry: pressure and temperature monitors, intended to be implanted in the brain, that completely dissolve within a few weeks. The news, published as a research letter in the journal Nature, described a demonstration of the devices in rats, using soluble wires to transmit the signals, as well as the demonstration of a wireless version, though the data transmission circuit, at this point, is not completely resorbable.

The technology, the Nature letter reports, can be adapted to sense fluid flow, motion, pH, and other parameters, and could be implanted in the heart, other organs, or in the skin.

imgPhoto: John Rogers/University of Illionis at Urbana-Champaign

The team at the University of Illinois built what are essentially microelectromechanical systems (MEMS) out of a membrane of polylactic-co-glycolic acid, a biodegradable polymer common in medical applications such as dissolvable stitches. This membrane sits on a substrate of nanoporous silicon or a metal foil. The foil is etched with trenches that create an air cavity, allowing the membrane to deflect in response to pressure changes in the surrounding fluid. A piezoresistive element constructed from Rogers’ classic stretchable serpentine coils detects the changes. The structure is stable for at least five days, but completely dissolves after three weeks in the body. Rogers expects the neurosurgeons at Washington University in St. Louis who are testing the device in rats to move into more extensive studies with larger animals; human trials could begin in perhaps five years.

Meanwhile, Rogers hopes to continue to improve the technology, pushing its useful life to four weeks before the devices are significantly resorbed. 

But next up for Rogers and his team: resorbable devices that go beyond sensing to actively help in treatment. For example, Rogers hopes to build a resorbable device that could electrically stimulate damaged nerves to accelerate the healing, as well as programmable devices that could release timed doses of drugs. 

The Conversation (0)

A New Treatment for Arthritis: Vagus-Nerve Stimulation

Studies will soon show whether electroceuticals outperform pharmaceuticals

5 min read
A tablet computer, a smartphone, a grey belt with white stripes, a grey disc, and a small silver rectangle with a wire curled beside it.

Galvani’s system includes a nerve stimulator that attaches to the splenic nerve.

Galvani Bioelectronics

Monique Robroek once had such crippling arthritis that, even with the best available medications, she struggled to walk across a room. But thanks to an electronic implant fitted under her skin, she managed to wean herself off all her drugs and live pain-free for nearly a decade—until recently, when a viral illness made her rheumatoid arthritis (RA) flare up again.

This article is part of our special report Top Tech 2023.

Robroek’s long remission is “very impressive” and rare among patients with RA, says her doctor Frieda Koopman, a rheumatologist at Amsterdam UMC, in the Netherlands. Robroek’s experience highlights the immense potential of so-called bioelectronic medicine, also known as electroceuticals, an emerging field of treatment for diseases that have traditionally been managed with pharmaceuticals alone.

Keep Reading ↓Show less